Exploring the Evolution and Efficacy of Targeted Therapy in Modern Oncology
OthersPage Navigation
Introduction
Over the past decades, the field of oncology has witnessed a significant shift from conventional, non-specific chemotherapies to more precise, molecularly targeted therapies.
Evolution of Targeted Therapies
Targeted therapies emerged from the understanding of cancer's molecular basis. The first-generation targeted drugs, such as imatinib, offered a glimpse into the potential of this approach. The landscape has evolved with advancements in genomics and bioinformatics, leading to the development of next-generation targeted therapies.
Efficacy of Targeted Therapies
The efficacy of targeted therapies is evident in their ability to improve patient outcomes. These therapies offer a personalized approach, targeting specific mutations in individual patients, thereby reducing side effects and improving response rates. However, challenges such as drug resistance remain.
Conclusion
Despite challenges, the evolution and efficacy of targeted therapies have revolutionized oncology, offering a more personalized and effective approach to cancer treatment. As our understanding of cancer's molecular complexities expands, so too will the potential of targeted therapies.
Recommended News For You
Recommended Articles For You
Featured News
Featured Articles
Featured Events
Featured KOL Videos
1.
We Don't Always Know What's 'Best' for Our Patients
2.
FAPI PET/CT enhances the staging of recently discovered breast cancer, according to comparative analysis.
3.
DBT Reduced Suicide Attempts in Adolescents with Bipolar Disorder.
4.
Axatilimab Demonstrates Effectiveness in Refractory/Recurrent GVHD.
5.
AI Framework Helps Classify Renal Tumors, Predict Outcomes
1.
The Genetics of Bernard Soulier Syndrome: What We Know so Far
2.
The New Frontier of Cancer Survivorship: Navigating the Long-Term Effects of Immunotherapy and Targeted Therapies
3.
Exploring the Mystery of Angiokeratomas on Scrotum: Causes, Symptoms and Treatment
4.
IGF2BP1 in Blood Disorders: Therapeutic Potential and Comprehensive Functional Insights
5.
Survivorship Care Planning Beyond Active Cancer Treatment: Advancing Care Continuity for Cancer Survivors
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part VI
2.
ESMO Breast Cancer 2022: P Reality X- A Restrospective Analysis
3.
Preventing Blood Clots: The Importance of Venous Thromboembolism Management
4.
Innovations in Hematology
5.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part I
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Welcome to Hidoc Dr.
Join to enhance your clinical skills and gain specialized in-depth medical knowledge